Whittier Trust’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
KWM
FCBT
EP
Whittier Trust's XPH Position: Q2 2026 in Review
Whittier Trust held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2026 at 619 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #896.
Whittier Trust first reported a position in XPH in Q4 2019 and has held it in 27 quarters since. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.
- Whittier Trust held 619 shares of State Street SPDR S&P Pharmaceuticals ETF worth $41.6K as of Q2 2026.
- Whittier Trust left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2026.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #896 holding.
- Whittier Trust first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2019 and has held it in 27 quarters since.
- 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.
Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.